Literature DB >> 22588260

Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells.

Nilasha Banerjee1, Christine Allen, Reina Bendayan.   

Abstract

The purpose of this study was to investigate the differential expression and function of organic anion-transporting polypeptides (OATPs) in breast epithelial and breast cancer cells. Estrone-3-sulfate (E3S), a substrate for 7 of 11 OATPs, is a predominant source of tumor estrogen in postmenopausal, hormone-dependent patients with breast cancer. Overexpression of certain OATPs (e.g., OATP1A2) reported in breast tumor tissues compared with surrounding normal tissues could contribute toward two to three times higher tumoral E3S concentration. Little is known about expression and function of other OATP family members among breast epithelial and breast cancer cells. We therefore compared gene and protein expression of seven OATPs (OATP1A2, OATP1B1, OATP1B3, OATP1C1, OATP2B1, OATP3A1, and OATP4A1) in immortalized breast epithelial cells (MCF10A), hormone-dependent breast cancer cells (MCF7), and hormone-independent breast cancer cells (MDA/LCC6-435, MDA-MB-231, and MDA-MB-468) by quantitative polymerase chain reaction and immunoblotting, respectively. Expression of solute carrier superfamily encoding for OATPs (SLCO) 1A2, 1B1, 1B3, 2B1, and 3A1 is exclusive, similar, or significantly higher in cancer cells compared with MCF10A cells. Protein expression of OATPs is found to be either exclusive or higher in cancer cells compared with MCF10A cells. Specificity of OATP-mediated E3S uptake is observed only in cancer cells, with the highest total uptake in MCF7 cells. Transport kinetics of E3S uptake demonstrates transport efficiency that is 10 times greater in the MCF7 cells than in the hormone-independent cells. These data suggest that OATPs could be a novel therapeutic target for hormone-dependent breast cancers, particularly in postmenopausal patients, where the major source of tumor estrogen is E3S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588260     DOI: 10.1124/jpet.112.192344

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  20 in total

1.  SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.

Authors:  Tanda M Dudenkov; James N Ingle; Aman U Buzdar; Mark E Robson; Michiaki Kubo; Irada Ibrahim-Zada; Anthony Batzler; Gregory D Jenkins; Tracy L Pietrzak; Erin E Carlson; Poulami Barman; Matthew P Goetz; Donald W Northfelt; Alvaro Moreno-Aspita; Clark V Williard; Krishna R Kalari; Yusuke Nakamura; Liewei Wang; Richard M Weinshilboum
Journal:  Breast Cancer Res Treat       Date:  2017-04-20       Impact factor: 4.872

Review 2.  Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.

Authors:  Eunpi Cho; R Bruce Montgomery; Elahe A Mostaghel
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

Review 3.  Role of Organic Anion-Transporting Polypeptides (OATPs) in Cancer Therapy.

Authors:  Nilay Thakkar; A Craig Lockhart; Wooin Lee
Journal:  AAPS J       Date:  2015-03-04       Impact factor: 4.009

Review 4.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

5.  (125)I-Labelled 2-Iodoestrone-3-sulfate: synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells.

Authors:  Nilasha Banerjee; T Robert Wu; Jason Chio; Ryan Kelly; Karin A Stephenson; John Forbes; Christine Allen; John F Valliant; Reina Bendayan
Journal:  Nucl Med Biol       Date:  2014-11-08       Impact factor: 2.408

6.  Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion.

Authors:  Arja Kaipainen; Ailin Zhang; Rui M Gil da Costa; Jared Lucas; Brett Marck; Alvin M Matsumoto; Colm Morrissey; Lawrence D True; Elahe A Mostaghel; Peter S Nelson
Journal:  Prostate       Date:  2019-08-02       Impact factor: 4.104

Review 7.  Targeted drug delivery to treat pain and cerebral hypoxia.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Pharmacol Rev       Date:  2013-01-23       Impact factor: 25.468

8.  Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin.

Authors:  Hartmut Glaeser; Krystyna Bujok; Ingrid Schmidt; Martin F Fromm; Kathrin Mandery
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-06-20       Impact factor: 3.000

9.  Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Authors:  Yiying Huang; Md Tozammel Hoque; Mohammad-Ali Jenabian; Kishanda Vyboh; Sana-Kay Whyte; Nancy L Sheehan; Pierre Brassard; Maud Bélanger; Nicolas Chomont; Courtney V Fletcher; Jean-Pierre Routy; Reina Bendayan
Journal:  J Antimicrob Chemother       Date:  2016-04-13       Impact factor: 5.790

10.  Estrone-3-sulphate, a potential novel ligand for targeting breast cancers.

Authors:  Nilasha Banerjee; Humphrey Fonge; Andrew Mikhail; Raymond M Reilly; Reina Bendayan; Christine Allen
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.